Medicare spends billions of dollars each year treating heart disease, diabetes, kidney disease, cancer and other illnesses caused or worsened by obesity. Yet for decades, federal law has barred the program from covering medicines prescribed to treat obesity itself.
In other words, Medicare has been willing to pay for the costly consequences of excess weight—while refusing to pay for drugs that could address the underlying disease.
The Trump administration has finally begun to correct that contradiction.
